2026 Surgical Oncology Faculty Symposium

January 29, 2026 to January 30, 2026

This course is designed to cover the most recent advances and guidelines in surgery and cancer therapy including methods of detection, treatment, newest technology, and research. We intend on having at least 30-35 attendees. These will be clinicians and researchers, from various surgical specialties.

Target Audience

Physicians

Learning Objectives

To learn new basic science technologies.
Discuss and implement new clinical practices.
Bridging the gap between basic science and clinical medicine.
Improve the working and teaching dynamic between faculty and trainees.

Course summary
Available credit: 
  • 9.50 ABS Accredited CME
  • 9.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 9.50 Attendance
Course opens: 
10/22/2025
Course expires: 
02/28/2026
Event starts: 
01/29/2026 - 10:00am EST
Event ends: 
01/30/2026 - 3:00pm EST
Add to calendar: 

PDF icon Program Agenda

Nemacolin
Farmington, PA
United States

Conflict of Interest Disclosure: 

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated

Jason Lohmueller has Grant/Research Support with Gencart Inc. Consultant with GenCART, Inc., NeoCell Technologies, Monarch Therapeutics. Privately Held Stockholder with enCART, Inc., Monarch Therapeutics.
Andrea Gambotto is privately held stockholder with GAPHAS PHARMACEUTICAL INC.
Jennifer Steel is a consultant with Juxtapose.
Jennifer Holder Murray is a consultant with Johnson & Johnson.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing  healthcare products used by or on patients. 


In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 
 

Available Credit

  • 9.50 ABS Accredited CME
  • 9.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 9.50 Attendance

Dilon Tech
Joule
Intuitive Surgical
Baxter Healthcare
J&J
Castle Bio
Natera
Abbvie
Vivus
ConMed
BD
Medtronic

Please login or register to take this course.